Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 710 for:    ABP 501
Previous Study | Return to List | Next Study

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05073315
Recruitment Status : Recruiting
First Posted : October 11, 2021
Last Update Posted : November 18, 2021
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 26, 2023
Estimated Study Completion Date : October 26, 2023